NOS2 and cancer: Given that iNOS was similarly reported to contribute to the promotion of cancer stem cell phenotype [47, 48], and the combinational treatment of melatonin and vemurafenib induced more expression inhibition of iNOS compared to single drug treatment, it is reasonable that besides hTERT, iNOS might also be involved in the abolished stemness maintenance caused by the combined drug application.